Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials*

Jean Louis Vincent; Roberta J. Navickis; Mahlon M. Wilkes

doi:10.1097/01.ccm.0000142574.00425.e9

Back

Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials*

Letter 2004 en

Abstract

1 min read

Albumin reduces morbidity in acutely ill hospitalized patients. Concomitant administration of albumin in the control group can obscure the effects of albumin on clinical outcome in randomized trials.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention? A Meta-Analysis of Cohort Studies and Controlled Trials

Jean Louis Vincent, Marc‐Jacques Dubois, Roberta J. Navickis, Mahlon M. Wilkes

Article2005

Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study

Jean Louis Vincent, Yasser Sakr, Konrad Reinhart, Charles L. Sprung, Herwig Gerlach, V. Marco Ranieri

Article2005

Morbidity in Hospitalized Patients Receiving Human Albumin: A Meta-Analysis of Randomized, Controlled Trials

Jean Louis Vincent, Roberta J. Navickis, Mahlon M. Wilkes

Article2008

Multicenter, randomized, controlled trials evaluating mortality in intensive care: Doomed to fail?

Gustavo A. Ospina‐Tascón, Gustavo Büchele, Jean Louis Vincent

Article2006

Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study*

Marc‐Jacques Dubois, Carlos Orellana-Jimenez, Christian Mélot, Daniel De Backer, Jacques Berré, Marc Leeman, Serge Brimioulle, Olivier Appoloni, Jacques Créteur, Jean Louis Vincent